CPHI Europe

CPHI Milan 2024: Navigating CMC Challenges for GLP-1 and Oral Peptides
October 08, 2024

Andrew Lewis, PhD, Chief Scientific Officer, Quotient Sciences, discussed the CMC challenges with GLP-1 and oral peptides during CPHI Milan.

CPHI Milan 2024: Compliance and Automation in Aseptic Processing
October 08, 2024

Pharmaceutical Technology Europe chats with Klaus Ullherr, senior product manager at Syntegon, about challenges facing companies when trying to comply with Annex 1 and how automated systems can help.

CPHI Milan 2024: Trends in Oral Solid Dosage Forms
October 08, 2024

Pharmaceutical Technology Europe sat down with Uwe Hanenberg, Head of Product Implementation at Recipharm, to talk about key trends shaping the oral solid dosage market, including technology advances and industry investments.

Cellevate Plans Pre-Launch of First Nanofiber Microcarriers for Viral Vector Manufacturing at CPHI Milan
October 07, 2024

The nanofiber microcarriers are the first of their kind for manufacturing viral vectors used in gene therapy production, according to Cellevate.

Enzene to Launch Continuous Manufacturing Technology at CPHI Milan 2024
October 07, 2024

The CDMO will be launching its EnzeneX 2.0 continuous manufacturing for biologics technology during CPHI Milan, which is being held Oct. 8–10, 2024 in Milan, Italy.

ICE Pharma Touts Fully Recyclable Booth at Its CPHI Milan Exhibit
October 03, 2024

The stand at booth 4A41, carried over from last year in Barcelona, will be constructed of white honeycomb cardboard and linoleum, with material waste generated during production repurposed into seats and tables.

IMA Group Previews Its Showings Set for CPHI Milan
October 03, 2024

The group’s IMA Life division will present a robotic fill/finish solution that was awarded Best in Show at INTERPHEX 2023.

Neopac to Introduce New MMB Mini Tubes at CPHI Milan
October 01, 2024

The tubes are designed to provide an aluminum-free packaging solution for select pharmaceutical, dental, and ophthalmic products.

Bormioli Pharma Display at CPHI Milan to Include Low-Impact, Pharma-Grade Product Range
September 26, 2024

The EcoPositive range, which comprises 50% of Bormioli Pharma’s current standard catalog and is composed of three distinct sustainability approaches, offers more than 3000 industrial solutions, in glass and plastic.

CPHI Report: Biologics, Tides Approvals Will Surpass Small Molecules by 2027
September 12, 2024

Seventeen biologics and nine tides—five peptides and four oligonucleotides—were approved in 2023 alone, with further growth predicted.